These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15853175)

  • 21. Prophylaxis against venous thromboembolism in orthopedic surgery.
    Liu LT; Ma BT
    Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism deserves your attention.
    Samama CM
    Crit Care; 2001 Dec; 5(6):277-9. PubMed ID: 11737903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological effects and clinical applications of ultra low molecular weight heparins.
    Liu Z; Ji S; Sheng J; Wang F
    Drug Discov Ther; 2014 Feb; 8(1):1-10. PubMed ID: 24647152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboembolic diseases.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
    [No Abstract]   [Full Text] [Related]  

  • 25. Venous thromboembolism: a guide to prevention and treatment.
    Crowther M; McCourt K
    Nurse Pract; 2005 Aug; 30(8):26-9, 32-4, 39-43; quiz 44-5. PubMed ID: 16094200
    [No Abstract]   [Full Text] [Related]  

  • 26. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients.
    Spyropoulos AC
    Chest; 2005 Aug; 128(2):958-69. PubMed ID: 16100192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing postsurgical venous thromboembolism: pharmacological approaches.
    Tufano A; Coppola A; Cerbone AM; Ruosi C; Franchini M
    Semin Thromb Hemost; 2011 Apr; 37(3):252-66. PubMed ID: 21455859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update in the treatment of venous thromboembolism.
    Garcia DA; Spyropoulos AC
    Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulants in dermatology.
    Adya KA; Inamadar AC; Palit A
    Indian J Dermatol Venereol Leprol; 2016; 82(6):626-640. PubMed ID: 27320765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of venous thromboembolism in the elderly.
    Spyropoulos AC; Merli G
    Drugs Aging; 2006; 23(8):651-71. PubMed ID: 16964988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of fondaparinux for the prevention and treatment of venous thromboembolism.
    Turpie AG
    Expert Opin Drug Saf; 2005 Jul; 4(4):707-21. PubMed ID: 16011449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
    Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism: diagnosis and management of deep venous thrombosis.
    Ho WK; Hankey GJ; Lee CH; Eikelboom JW
    Med J Aust; 2005 May; 182(9):476-81. PubMed ID: 15865594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts for the prevention of venous thromboembolism.
    Bramlage P; Pittrow D; Kirch W
    Eur J Clin Invest; 2005 Mar; 35 Suppl 1():4-11. PubMed ID: 15701142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fondaparinux: a potential new therapy for HIT.
    Kuo KH; Kovacs MJ
    Hematology; 2005 Aug; 10(4):271-5. PubMed ID: 16085538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
    Brown A
    Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic considerations in the prevention and treatment of venous thromboembolism.
    Hawkins D
    Am J Health Syst Pharm; 2004 Dec; 61(23 Suppl 7):S18-21. PubMed ID: 15597575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended anticoagulation therapy for the primary and secondary prevention of venous thromboembolism.
    Blanchard E; Ansell J
    Drugs; 2005; 65(3):303-11. PubMed ID: 15669876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.